[Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
Popov
V V
VV
Kopitsa
N P
NP
Oparin
A L
AL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D001341:Autonomic Nervous System / Q000503:physiopathology; D002940:Circadian Rhythm; D015716:Electrocardiography, Ambulatory; D015444:Exercise / Q000502:physiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D005343:Fibrinolytic Agents